Joel D. Schilling, MD, PhD

Medical Director of Heart Transplant Program

Washington University in St. Louis (WU)

My lab investigates macrophage dysfunction in obesity and diabetes. In particular, we have been dissecting the role of resident and recruited myeloid cells in the liver during the development of non-alcoholic fatty liver disease using a variety of in vivo and ex vivo approaches. We have also been working with human livers to translate our findings to patients. We have also expanded our research to evaluate the impact of right on heart on liver biology and how this influences patient outcomes.